NADER EL-MALLAWANY to Lymphoma, Non-Hodgkin
This is a "connection" page, showing publications NADER EL-MALLAWANY has written about Lymphoma, Non-Hodgkin.
Connection Strength
0.914
-
Children's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30565.
Score: 0.563
-
Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2023 01; 64(1):234-237.
Score: 0.134
-
Safety analysis of high-dose methotrexate in pediatric non-Hodgkin lymphomas. Pediatr Blood Cancer. 2022 11; 69(11):e29940.
Score: 0.133
-
Adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016 05; 173(4):637-50.
Score: 0.085